Antengene Corporation Limited, a leading innovative global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for cancer and other life-threatening diseases, hosted two Investor R&D meetings this week to discuss the Company’s vision and R&D philosophy, strategy, capabilities and its commercial readiness to launch Xpovio® (Selinexor) in its markets. During the… Continue reading Treating Patients Beyond Borders – Antengene Successfully Hosted Its First R&D Day
Tag: Healthcare
HealthLevel Introduces New Capabilities Strengthening its Business Operations Platform as a Tool for Improving Performance
HealthLevel, Inc., innovator of Foundations, a business operations analytics platform for healthcare institutions, announces new capabilities that enable data insights to drive beneficial changes in end user behavior. This further differentiates Foundations from static business analytics platforms. These new capabilities, as well as the full product will be available for demonstration in the HealthLevel Booth… Continue reading HealthLevel Introduces New Capabilities Strengthening its Business Operations Platform as a Tool for Improving Performance
The Prostate Cancer Cell That Got Away
Cold Spring Harbor Laboratory (CSHL) Associate Professor Pavel Osten and Professor Lloyd Trotman have developed a new way to study the life history of prostate cancer in mice. The pair combined their expertise in whole-organ imaging and prostate cancer to track how prostate cancer cells grow into tumors and spread to other organs. Their method… Continue reading The Prostate Cancer Cell That Got Away
Johnson & Johnson Announces Plans to Accelerate Innovation, Serve Patients and Consumers, and Unlock Value through Intent to Separate Consumer Health Business
Johnson & Johnson (the “Company”) (NYSE: JNJ) announced its intent to separate the Company’s Consumer Health business, creating a new publicly traded company. The planned separation would create two global leaders that are better positioned to deliver improved health outcomes for patients and consumers through innovation, pursue more targeted business strategies and accelerate growth. Following… Continue reading Johnson & Johnson Announces Plans to Accelerate Innovation, Serve Patients and Consumers, and Unlock Value through Intent to Separate Consumer Health Business
Johnson & Johnson Enters into Agreement to Provide its Single-Shot COVID-19 Vaccine for the World’s Most Vulnerable People through Novel Humanitarian Buffer
Johnson & Johnson (NYSE: JNJ) has entered into an agreement with the U.S. Government and Gavi, the Vaccine Alliance (Gavi), to enable access to its single-shot COVID-19 vaccine through a novel mechanism – the COVAX Humanitarian Buffer – that will serve to protect the world’s most vulnerable people. The first deliveries to the COVAX Humanitarian… Continue reading Johnson & Johnson Enters into Agreement to Provide its Single-Shot COVID-19 Vaccine for the World’s Most Vulnerable People through Novel Humanitarian Buffer
Essence SmartCare Wins CES 2022 Innovation Award for VitalOn Telehealth Platform
Essence SmartCare, a leader in IoT-based remote care solutions, part of Essence Group, announced that it has been named a CES® 2022 Innovation Awards Honoree for the VitalOn comprehensive remote patient monitoring (RPM) platform. This year’s CES Innovation Awards program received a record high number of over 1800 submissions. The announcement was made ahead of… Continue reading Essence SmartCare Wins CES 2022 Innovation Award for VitalOn Telehealth Platform
Amyris Announces JV Partnership With ImmunityBio For Next Generation COVID-19 RNA Vaccine
Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world to sustainable consumption through its Lab-to-Market operating platform, announced it has entered into a 50:50 joint venture arrangement with ImmunityBio, Inc. (Nasdaq: IBRX), a clinical-stage immunotherapy company, to accelerate the commercialization of a leading next-generation COVID-19 vaccine. The parties have signed a binding… Continue reading Amyris Announces JV Partnership With ImmunityBio For Next Generation COVID-19 RNA Vaccine
Cue Health To Launch Direct-To-Consumer Virtual Health Platform Featuring Its COVID-19 Self-Test Trusted By Google, Mayo Clinic, The NBA, And MLB
Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced that its direct-to-consumer (DTC) virtual health platform will launch on November 15th, making Cue’s first-of-its-kind molecular COVID-19 test available to people across the United States through Cue’s new eCommerce site and in-app shop. Individual consumers will now be able to harness the power of Cue’s… Continue reading Cue Health To Launch Direct-To-Consumer Virtual Health Platform Featuring Its COVID-19 Self-Test Trusted By Google, Mayo Clinic, The NBA, And MLB
NoviSystems Launches Data Analytics Solution for More Efficient Drug Manufacturing
NoviSystems Inc., a company that empowers data-driven decision making, has commercially launched Fusion Analytics for Quality Systems, an analytics solution for improving operational performance at pharmaceutical and biopharmaceutical manufacturing facilities in the new era of individualized medicine. “With the emergence of cell/gene therapy and individualized treatments, Fusion Analytics for Quality Systems is even more essential… Continue reading NoviSystems Launches Data Analytics Solution for More Efficient Drug Manufacturing
Reckitt to Implement Its Largest Ever Targeted Hygiene Program at COP26 to Protect 25,000+ Delegates
Reckitt, the maker of Lysol and Dettol, has developed a tailor-made targeted hygiene program to help protect attendees of COP26, one of the largest in-person events to be held since the beginning of the pandemic. Reckitt’s protocols and products will help reduce the spread of illness-causing germs across 50,000 hotspots in a conference space larger… Continue reading Reckitt to Implement Its Largest Ever Targeted Hygiene Program at COP26 to Protect 25,000+ Delegates